BioCentury
ARTICLE | Company News

BDX, MLNM, TriPath collaborate

August 2, 2001 7:00 AM UTC

Under its strategic alliance with Millennium (MLNM), Becton Dickinson (BDX) selected TriPath Imaging (TPTH) to develop and market molecular diagnostics and pharmacogenomic tests for malignant melanoma...